M16.0 M54.5 M53.2 M53.8 M53.9 M54.6 M54.8 M54.9 M99.02 M99.03 M99.04 M99.82 M99.83 M99.84 M99.92 M99.93 M99.94 M42.0 M42.1 M42.9 M99.85 M99.86 M99.95 M99.96 M25.55 M25.85 M25.95 M17.0 M99.86 M99.96 M25.56 M25.86
Conditions
Interventions
Group 1: Arm 1: Retrospective recording of treatment using Vivira app. It is an intraindividual control: i.e. the study is single-armed, the control is the pre-finding (=historical finding) of the sam
Sponsors
Vivira Health Lab GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with chronic musculoskeletal pain and a baseline pain score greater than 1 on the rating scale as of 01/01/2020.
Exclusion criteria
Exclusion criteria: - Patients who were unable to follow the exercise protocol. - Patients with severe visual problems - No pain, pain score=0 - Discontinuation without pain score after week 2: these patients were considered as study users but not ITT users. - Non-premium users: these patients were also considered test users and not ITT users. They were trial users who only tried Vivira for a few days free of charge. - Prescription of analgesics - acute malignant disease - dementia - drug or alcohol abuse - previous use of an exercise therapy DiGA (Vivira, Kaia, etc.) - limited legal capacity - significantly impaired vision or blindness - severe internal illness (condition following heart attack, severe organ failure, need for dialysis, etc.) - severe neurological disorders (stroke, paralysis, multiple sclerosis, convulsions, etc.) - rheumatic disease - osteoporosis - pregnancy - bleeding tendency / hemophilia - gait instability and frequent falls - acute herniated disc or other disease with radiation to the legs (radiculopathy, sensorimotor failure) - herniated disc in the past - Spinal infection in the past or acutely - Spinal surgery - Spinal tumor - Injury to the spine - Joint replacement (TEP) or partial joint replacement - Osteotomy (an operation to correct the leg axis) - joint infection in the past or acutely - free joint body - Osteochondrosis dissecans or bone necrosis - Injury to the knee or hip joint - Hip dysplasia - Arthrodesis (joint fusion) in either knee or hip joint - Acute instability of the knee or hip joint - Knee or hip surgery in the last year - Clinically relevant bone marrow edema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VNRS (verbal-numerical rating scale) of pain after 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Proprietary functional test | — |
Countries
Germany
Contacts
Public ContactHans-Peter Zenner
Clinical Research Organization HP Zenner Clinical GmbH&Co KG
Outcome results
None listed